The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Investigation Report on China's Rituximab Market 2021-2025
US$ 2,600.00
Rituximab is a monoclonal antibody to target cells that have the CD20 marker on their surface. It is mainly used to treat diseases caused by excessive B lymphocytes, including lymphoma, chronic lympho...
April 2021
50 pages
Investigation Report on China's Tacrolimus Market 2021-2025
US$ 2,600.00
Tacrolimus is a macrolide antibiotic and is also a new immunosuppressant. It is available in a variety of dosage forms. The ointment is used for moderate to severe atopic dermatitis where traditional...
April 2021
50 pages
Investigation Report on Chinese Atorvastatin Market 2021-2025
US$ 2,600.00
... demand for Atorvastatin. TOPICS COVERED: Development environment of Atorvastatin in China Sales of Atorvastatin in China Prices of Atorvastatin in China Major Atorvastatin manufacturers in China Market share of Atorvastatin by dosage form in China Prospect of Chinese Atorvastatin Market, 2018-2022 ...
April 2021
50 pages
Investigation Report on China's Ambroxol Market, 2021-2025
US$ 2,600.00
... Pharmaceutical (Qianshan) Co., Ltd. Ambroxol is sold in China in the dosage forms of ... China Size of China's Ambroxol market Competitive landscape of China's Ambroxol market Prices of Ambroxol in China Analysis on factors affecting the development of China's Ambroxol market Prospect of China's Ambroxol ...
April 2021
50 pages
Investigation Report on China's Recombinant Lispro Insulin Market, 2021-2025
US$ 2,600.00
... market in China Market size of Recombinant Lispro Insulin in China Major Recombinant Lispro Insulin manufacturers in China Prices of Recombinant Lispro Insulin in China Major factors affecting the development of China's Recombinant Lispro Insulin market Prospect of China's Recombinant Lispro Insulin market
April 2021
50 pages
Investigation Report on Chinese Apixaban Market 2021-2025
US$ 2,600.00
Anticoagulation therapy plays an important role in the prevention and treatment of thromboembolic diseases. The two most famous drugs are Rivaroxaban and Apixaban, mainly used to prevent and treat ven...
April 2021
50 pages
Investigation Report on Chinese Budesonide Market 2021-2025
US$ 2,600.00
Budesonide is an adrenal cortex hormone medicine. It is available in different forms, such as inhalant, nasal spray, and so on. The inhalation form is used to treat asthma and chronic obstructive pulm...
April 2021
50 pages
Investigation Report on Chinese Dezocine Market, 2021-2025
US$ 2,600.00
Dezocine is an opioid analgesic that relieves pain. Dezocine was launched in China in 2009 and has been widely used in general anesthesia induction, postoperative analgesia, and preemptive analgesia....
April 2021
50 pages
Global Bleeding Disorders Drugs Market, By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others), By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By Gender (Male v/s Female), By End User (Hospitals, Hemophilia Treatment Centers, Research Institutes, Others), By Region, Competition Forecast & Opportunities, 2026
US$ 4,900.00
Global Bleeding Disorders Drugs Market is expected to grow at robust rate with a CAGR of 8.44% in value terms to reach USD24078.16 million by 2026 on account of increasing concerns for blood disorders...
April 2021
116 pages
Global Generic Drugs Market, By Type (Small Molecule Generics vs Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House vs Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Company, By Region, Forecast & Opportunities, 2026
US$ 4,900.00
Global generic drugs market was valued at USD371.04 billion in 2020 and is anticipated to reach USD564.43 billion until 2026 by witnessing a CAGR of 7.08% during the forecast period. The global generi...
April 2021
118 pages
Alopecia (Dermatology) - Drugs in Development, 2021
US$ 2,500.00
Alopecia (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alopecia - Drugs in Development, 2021, provides an overv...
March 2021
249 pages
Anthrax (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Anthrax (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anthrax - Drugs in Development, 2021, provides an...
March 2021
124 pages
Botulism (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Botulism (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Botulism - Drugs in Development, 2021, provides a...
March 2021
38 pages
Cholera (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Cholera (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cholera - Drugs in Development, 2021, provides an...
March 2021
64 pages
Colitis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Colitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colitis - Drugs in Development, 2021, provides an ov...
March 2021
124 pages
Diarrhea (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Diarrhea (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diarrhea - Drugs in Development, 2021, provides an...
March 2021
175 pages
